课题基金 / 基金详情

STUDY OF SELECTED LATE EFFECTS IN PATIENTS TREATED FOR NONHODGKINS LYMPHOMA

STUDY OF SELECTED LATE EFFECTS IN PATIENTS TREATED FOR NONHODGKINS LYMPHOMA
对接受非霍奇金淋巴瘤治疗的患者的选定迟发效应的研究
批准号:
5219313
负责人:
JULIE BLATT
金额:
$0.0万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

JULIE BLATT的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We hypothesize that patients treated during childhood with non-Hodgkin's lymphoma may have an increased incidence of cardiac, gonadal or pulmonary toxicity and a higher incidence of second malignancies if they have had high cumulative doses of certain chemotherapies. The identification of chemotherapy regimens which have lesser toxicity with equal efficacy may help up to design less toxic studies. Patients will be undergoing therapy directed evaluations of these various organ systems. This study is CCG-wide and based on a population of patients who were treated with randomly assigned treatment regimens.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STUDY OF SELECTED LATE EFFECTS IN PATIENTS TREATED FOR NONHODGKINS LYMPHOMA
PEDIATRIC PHASE I TRIAL AND PHARMACOKINETIC STUDY OF LGC1057
PHASE I STUDY OF TOPOTECAN AND CISPLATIN IN THE TREATMENT OF SOLID TUMORS
THERAPEUTIC ROLE OF FERRITIN IN NEUROBLASTOMA